Part 2: Choosing the Right Autosomal DNA Testing Shouldn’t Be a Random Process

Dr. Tim Janzen DNA Ancestry Expert

Natural Selection is not a random process – neither should your personal selection of autosomal DNA testing (for genealogical purposes) be random. Dr. Tim Janzen, a family practice physician in Portland, Oregon, and a long-time genetic genealogist, walks you through the different tests and what they have to offer. Dr. Janzen serves as one of six 23andMe Ancestry Ambassadors, as well as on the ISOGG Y-DNA Haplogroup Tree committee. He is a leading researcher in autosomal DNA for genealogy.

Photo courtesy of Tim Janzen

Photo courtesy of Tim Janzen

There are currently three primary genetic genealogy companies that offer autosomal DNA testing for genealogical purposes: 23andMe, Family Tree DNA (FTDNA), and Ancestry.com. The tests offered by these companies are similar in that they all use “SNP chips” that test between 700,000 and 967,000 specific point mutations called SNPs (single nucleotide polymorphisms). 23andMe’s test includes the most SNPs in its test.

All three companies provide you with a list of closest matches in their databases. The number of matches that you will have depends on the number of people in the company’s database, the number of people with your ancestral background who have been tested, and the criteria that the company sets for what constitutes a match. Ancestry.com’s product, AncestryDNA, has the lowest criteria for a match, which results in more distantly related people showing up on your match list.

23andMe and Family Tree DNA’s product (“Family Finder”), both provide you with the information about the specific DNA segments that you share with your matches, including which chromosomes the matching segments are located on, the number of SNPs in the matching segment, and the start and stop positions on the chromosomes for each matching segment. This information is crucial for genetic genealogists who are trying to trace their family trees since the matching segment information allows you to map your chromosomes, which involves determining which ancestor or ancestral couple the matching segments were inherited from. However, Ancestry.com’s autosomal product, AncestryDNA, currently does not provide this information, which is a major disadvantage to this test.

The only current advantages to Ancestry.com’s test include their introductory price, which is lower at $99 than that of its competitors, and the fact that Ancestry.com phases the data before the match list is generated, which reduces the number of false positive matches that appear on your match list. 23andMe’s test is currently priced at $299 and Family Tree DNA’s test is currently priced at $289. I estimate that 23andMe at this time has about 160,000 people in its database, FTDNA has about 40,000 people in its Family Finder database, and Ancestry.com has about 65,000 in its AncestryDNA database. 23andMe’s test offers health-related information as part of the test, which is something that neither FTDNA’s Family Finder nor AncestryDNA includes. A much higher proportion of the people who have taken 23andMe’s test have done relatively limited genealogical research, which makes it more challenging when trying to contact your 23andMe matches.

I believe that the most cost-effective approach for the average genetic genealogist is to do the 23andMe test first and then import the raw data file into the FTDNA Family Finder database, which currently costs $89. This saves about $200 as compared to ordering both tests separately. You have to be an Ancestry.com member in order to do the AncestryDNA test, and you must receive a personal email from Ancestry.com inviting you to do the test before you can order it. I believe that it is reasonable for Ancestry.com subscribers to do the AncestryDNA test, but people who do the test need to be aware that there are some significant disadvantages to the AncestryDNA test relative to the 23andMe and FTDNA Family Finder tests, since Ancestry.com doesn’t provide the raw data files to its customers and also doesn’t provide the matching segment data.

For a more comprehensive analysis of the differences between these three autosomal DNA tests, I would suggest you consult the chart I created, which compares the features of the three tests in some depth.

If you are interested in receiving a consultation with Dr. Janzen, please contact Record Click for more information.